OrthoAccel Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company’s innovations is AcceleDent, an FDA-cleared, Class II medical device that speeds up orthodontic treatment with fixed braces or clear aligners by as much as 50 percent.

AcceleDent utilizes patented SoftPulse Technology, which is demonstrated to speed up bone remodeling, to accelerate orthodontic treatment. The pulsating forces like those AcceleDent produces are clinically proven to accelerate orthodontic treatment and aid in more predictable case outcomes. The newly-released, next-generation Acceledent Optima is the first and only orthodontic device that directly connects patients and practices via smartphone interface.

InnovaHealth Partners’ predecessor firm, HealthpointCapital, made its initial investment in OrthoAccel in 2012. John McCormick serves as a Director of OrthoAccel Technologies, Inc.